Back to mobile site

More on NXTC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+65.8% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NextCure Inc. (NQ:NXTC)
Delayed: 6.12 +0.45 (7.94%)
Prev. Close $5.67  
Open$5.87 
52 Wk High$ 
52 Wk Low$ 
Day High$6.27 
Day Low$5.67 
P/E N/A  
EPS$ 
Volume103,911 

Friends, Peers and Foes (?): AKRO (more...)

Aug 18, 2026 05:30 PM Form S-4 NextCure, Inc.
Aug 14, 2026 09:33 PM Form SCHEDULE 13G NextCure, Inc. Filed by: ADAR1 Capital Management, LLC
Aug 14, 2026 08:58 PM Form SCHEDULE 13G/A NextCure, Inc. Filed by: Ikarian Capital, LLC
Aug 14, 2026 01:10 PM Form SCHEDULE 13G/A NextCure, Inc. Filed by: Squadron Capital Management LLC
Aug 13, 2026 04:05 PM Form SCHEDULE 13G/A NextCure, Inc. Filed by: Affinity Asset Advisors, LLC
Aug 13, 2026 06:59 AM H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC)
Aug 12, 2026 12:07 PM Form SCHEDULE 13G NextCure, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2026 11:35 AM Form 4 NextCure, Inc. For: Aug 10 Filed by: Simcere Pharmaceutical Group Ltd
Aug 10, 2026 04:02 PM Form 425 NextCure, Inc. Filed by: NextCure, Inc.
Aug 10, 2026 07:01 AM Avere Therapeutics raises $500M in private placement for drug program
View All Articles

Entities mentioned with NXTC

View All Entities